- Home
- NEGG vs CSBR Comparison
NEGG vs CSBR Comparison
Compare NEGG & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- CSBR
- Stock Information
- Founded
- NEGG 2001
- CSBR 1985
- Country
- NEGG United States
- CSBR United States
- Employees
- NEGG N/A
- CSBR N/A
- Industry
- NEGG Other Specialty Stores
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEGG Consumer Discretionary
- CSBR Health Care
- Exchange
- NEGG Nasdaq
- CSBR Nasdaq
- Market Cap
- NEGG 122.3M
- CSBR 123.2M
- IPO Year
- NEGG 2010
- CSBR 1986
- Fundamental
- Price
- NEGG $49.94
- CSBR $6.60
- Analyst Decision
- NEGG
- CSBR Strong Buy
- Analyst Count
- NEGG 0
- CSBR 1
- Target Price
- NEGG N/A
- CSBR $12.00
- AVG Volume (30 Days)
- NEGG 1.4M
- CSBR 26.8K
- Earning Date
- NEGG 08-29-2025
- CSBR 09-11-2025
- Dividend Yield
- NEGG N/A
- CSBR N/A
- EPS Growth
- NEGG N/A
- CSBR N/A
- EPS
- NEGG N/A
- CSBR 0.33
- Revenue
- NEGG $1,313,127,000.00
- CSBR $56,944,000.00
- Revenue This Year
- NEGG N/A
- CSBR $9.30
- Revenue Next Year
- NEGG N/A
- CSBR $31.17
- P/E Ratio
- NEGG N/A
- CSBR $20.36
- Revenue Growth
- NEGG N/A
- CSBR 13.54
- 52 Week Low
- NEGG $3.32
- CSBR $3.60
- 52 Week High
- NEGG $137.84
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- NEGG 44.81
- CSBR 44.79
- Support Level
- NEGG $86.27
- CSBR $6.51
- Resistance Level
- NEGG $137.84
- CSBR $7.66
- Average True Range (ATR)
- NEGG 19.91
- CSBR 0.45
- MACD
- NEGG -6.37
- CSBR 0.04
- Stochastic Oscillator
- NEGG 1.39
- CSBR 24.88
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.